Maryville, MO, United States of America

Christopher Riley

This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Aponia Laboratories, Inc., M.p.f., Inc.. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Riley. Retrieved from https://idiyas.com/inventor/christopher-riley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7


 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Washington, DC (US) (2011 - 2014)
  • Maryville, MO (US) (2015 - 2022)

Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Path of Christopher Riley

Introduction

Christopher Riley, an inventive mind hailing from Maryville, Missouri, has made notable contributions to the field of pharmaceuticals with a total of six patents. His work primarily focuses on transdermal compositions, reflecting his commitment to advancing medical treatments for both humans and animals.

Latest Patents

Among his recent innovations, Riley has developed a significant patent titled "Transdermal compositions of ibuprofen and methods of use thereof." This inventive work involves a unique transdermal composition that combines ibuprofen or its salts with a gelling agent. Such compositions can be utilized to effectively treat a variety of disorders including pain, inflammation, arthritis, muscle spasms, and other associated symptoms.

Career Highlights

Throughout his career, Christopher Riley has been associated with reputable companies such as Aponia Laboratories, Inc. and M.P.F., Inc. His role in these organizations has allowed him to cultivate his innovative ideas and contribute to the development of effective pharmaceutical solutions.

Collaborations

Riley's inventive journey has also been marked by collaborations with prominent colleagues, including Haigang Chen and Gareth Winckle. These partnerships have helped foster an environment of creativity and advancement, further enhancing the impact of their collective work.

Conclusion

Christopher Riley's dedication to innovation in transdermal drug delivery systems underscores the importance of continuous research in addressing medical challenges. His patents not only showcase his ingenuity but also offer promising solutions to common pain and discomfort experienced by many individuals and animals, solidifying his position as a valuable innovator in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…